Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana

International Journal of Medical Microbiology - Tập 300 - Trang 489-495 - 2010
Susanne Homolka1, Christian G. Meyer2, Doris Hillemann1, Ellis Owusu-Dabo3,4, Ohene Adjei3, Rolf D. Horstmann2, Edmund N.L. Browne4, Amanua Chinbuah5, Ivy Osei5, John Gyapong5, Tanja Kubica1, Sabine Ruesch-Gerdes1, Stefan Niemann1
1Research Centre Borstel, National Reference Centre for Mycobacteria, Borstel, Germany
2Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
3Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Ghana
4Dept. of Community Health, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Ghana
5Health Research Unit, Ghana Health Service, Accra, Ghana

Tài liệu tham khảo

Afanas’ev, 2007, Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation, J. Antimicrob. Chemother., 59, 1057, 10.1093/jac/dkm086

Ali, 2009, M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes, Scand. J. Infect. Dis., 41, 37, 10.1080/00365540802570519

Allix-Beguec, 2008, Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates, J. Clin. Microbiol., 46, 2692, 10.1128/JCM.00540-08

Bakonyte, 2003, Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania, Antimicrob. Agents Chemother., 47, 2009, 10.1128/AAC.47.6.2009-2011.2003

Bercion, 1997, Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995, Int. J. Tuberc. Lung Dis., 1, 110

Billington, 1999, Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis, Antimicrob. Agents Chemother., 43, 1866, 10.1128/AAC.43.8.1866

Corbett, 2003, The growing burden of tuberculosis: global trends and interactions with the HIV epidemic, Arch. Intern. Med., 163, 1009, 10.1001/archinte.163.9.1009

Dalla Costa, 2009, Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America, BMC Microbiol., 9, 39, 10.1186/1471-2180-9-39

de Jong, 2009, Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia, J. Clin. Microbiol., 47, 994, 10.1128/JCM.01216-08

Deutsches Institut für Normung (DIN), 1996

DeVito, 2003, Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants, Antimicrob. Agents Chemother., 47, 188, 10.1128/AAC.47.1.188-195.2003

Doustdar, 2008, Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran, Microb. Drug Resist., 14, 273, 10.1089/mdr.2008.0842

Evans, 2009, Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa, J. Antimicrob. Chemother., 63, 11, 10.1093/jac/dkn433

Frothingham, 1999, Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa, J. Clin. Microbiol., 37, 1921, 10.1128/JCM.37.6.1921-1926.1999

Gagneux, 2006, The competitive cost of antibiotic resistance in Mycobacterium tuberculosis, Science, 312, 1944, 10.1126/science.1124410

Githui, 2004, Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya, Int. J. Tuberc. Lung Dis., 8, 352

Haas, 1997, Comparison of DNA fingerprint patterns of isolates of Mycobacterium africanum from east and west Africa, J. Clin. Microbiol., 35, 663, 10.1128/JCM.35.3.663-666.1997

Haas, 1997, Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa, Antimicrob. Agents Chemother., 41, 1601, 10.1128/AAC.41.7.1601

Hillemann, 2005, Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany, Antimicrob. Agents Chemother., 49, 1229, 10.1128/AAC.49.3.1229-1231.2005

Homolka, 2008, High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone, BMC Microbiol., 8, 103, 10.1186/1471-2180-8-103

Kamerbeek, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J. Clin. Microbiol., 35, 907, 10.1128/JCM.35.4.907-914.1997

Kent, 1985, A guide for level III laboratory

Kiepiela, 2000, Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa, Tuberc. Lung Dis., 80, 47, 10.1054/tuld.1999.0231

Lawn, 2001, Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment, West Afr. J. Med., 20, 92

Lipin, 2007, Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia, Clin. Microbiol. Infect., 13, 620, 10.1111/j.1469-0691.2007.01711.x

Mariam, 2004, Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis, Antimicrob. Agents Chemother., 48, 1289, 10.1128/AAC.48.4.1289-1294.2004

Meissner, 1969, The so-called African mycobacteria strains from the tropical West Africa, Zentralbl. Bakteriol. Orig., 211, 69

Mokrousov, 2002, High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001, Antimicrob. Agents Chemother., 46, 1417, 10.1128/AAC.46.5.1417-1424.2002

Musser, 1995, Antimicrobial agent resistance in mycobacteria: molecular genetic insights, Clin. Microbiol. Rev., 8, 496, 10.1128/CMR.8.4.496

Niemann, 2004, The species Mycobacterium africanum in the light of new molecular markers, J. Clin. Microbiol., 42, 3958, 10.1128/JCM.42.9.3958-3962.2004

Niemann, 2002, Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda, J. Clin. Microbiol., 40, 3398, 10.1128/JCM.40.9.3398-3405.2002

Owusu-Dabo, 2006, Mycobacterium tuberculosis drug resistance, Ghana, Emerg. Infect. Dis., 12, 1171, 10.3201/eid1207.051028

Park, 2005, Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea, J. Microbiol. Methods, 63, 165, 10.1016/j.mimet.2005.03.002

Ramaswamy, 1998, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tuberc. Lung Dis., 79, 3, 10.1054/tuld.1998.0002

Riska, 2000, Molecular determinants of drug resistance in tuberculosis, Int. J. Tuberc. Lung Dis., 4, S4

Slayden, 2000, The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis, Microbes Infect., 2, 659, 10.1016/S1286-4579(00)00359-2

Taniguchi, 1996, Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis, FEMS Microbiol. Lett., 144, 103, 10.1111/j.1574-6968.1996.tb08515.x

Tracevska, 2002, Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia, J. Clin. Microbiol., 40, 3789, 10.1128/JCM.40.10.3789-3792.2002

Tudo, 2004, Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology, Int. J. Tuberc. Lung Dis., 8, 15

van der Werf, 1989, High initial drug resistance in pulmonary tuberculosis in Ghana, Tubercle, 70, 249, 10.1016/0041-3879(89)90019-6

van Embden, 1993, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology, J. Clin. Microbiol., 31, 406, 10.1128/JCM.31.2.406-409.1993

Warren, 2009, The clinical relevance of Mycobacterial pharmacogenetics, Tuberculosis (Edinb.), 89, 199, 10.1016/j.tube.2009.03.001

World Health Organization, 2007

World Health Organization, 2009

Zaczek, 2009, Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin, BMC Microbiol., 9, 10, 10.1186/1471-2180-9-10

Zhang, 2000, Genetics of drug resistance in Mycobacterium tuberculosis, 235

Thông tin
Thông tin xuất bản

International Journal of Medical Microbiology

Tập 300

489-495

Thông tin tác giả